MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients

Objective: Tyrosine kinase inhibitors (TKIs) are used for the treatment of metastatic differentiated (DTC), poorly differentiated (PDTC) and medullary (MTC) thyroid cancer. Several adverse events (AEs) have been reported in almost all patients (pts) treated with TKIs. One of the less known AE relate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Autores principales: Valerio, Laura, Matrone, Antonio, Agate, Laura, Bottici, Valeria, Viola, David, Cappagli, Virginia, Giani, Carlotta, Molinaro, Eleonora, Elisei, Rossella
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Thyroid
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209016/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1647
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares